⚖️
Healthcare & Biotech Regulatory Redlines & Legal Risk 2013 - 2015

跨国药企的销售合规案 (GSK China):一家药企的销售团队,为什么会被追究到公司层面?

当销售目标只能靠不合规手段完成,公司的考核体系就是共犯

跨国药企的销售合规案 (GSK China):巅峰期跨国药企在中国的重要业务实体,产品覆盖处方药与疫苗,销售网络遍布全国医院与渠道,是在华规模领先的外资药企之一;终局是因通过第三方套现进行商业贿赂被查处,公司与多名高管被判处罚金与刑罚,罚款金额达数十亿元人民币,此后大幅调整销售模式与合规体系。

See the patterns
公开报道整理 待核查 Figures as of 2015 1 sources What do these mean?

How to read this bar

This bar states plainly what we know and what we have checked, so you can judge it yourself.

· Review status: “pending” means no editor has checked it against the sources yet; “checked” means key facts match the sources.

· Figures as of: the year the numbers are current to; later changes are out of scope.

· Sources: listed one by one at the bottom of the page. “Primary” means official filings, annual reports or regulator documents.

· Corrections: every change and its basis is published — nothing is edited silently.

Editorial policy → Editorial policy: the full inclusion rules, verification process, AI disclosure and correction promise.

No English translation for this case yet — showing the stored original.
Peak valuation

跨国药企在中国的重要业务实体,产品覆盖处方药与疫苗,销售网络遍布全国医院与渠道,是在华规模领先的外资药企之一

Final cost

因通过第三方套现进行商业贿赂被查处,公司与多名高管被判处罚金与刑罚,罚款金额达数十亿元人民币,此后大幅调整销售模式与合规体系

Attribution votes

5,280 votes cast

Community output

1 plans · 1 insights

Sponsored
把你亲历的失败写进来

投稿会先进入待审,通过后才进入公开目录和站点地图。

Root Causes Consensus Poll

Vote for the primary fatal error that caused this enterprise to collapse.

组织管理

以处方量为核心的考核体系

销售激励与合规边界冲突,违规成为完成任务的手段

1,737 votes (33%)
外部合规

通过第三方套现形成资金通道

旅行社等中间环节掩盖了资金用途,规避了内部审核

1,459 votes (28%)
战略

总部对当地模式的审查不足

跨区域管理存在信息落差,合规监督未能前置

1,181 votes (22%)
资本财务

罚款与业务调整造成重大损失

数十亿元罚款叠加销售模式调整,业务增速与市场份额受损

903 votes (17%)

Sources

1 sources

These are the references used to compile this case; the numbers match the [1][2] marks in the timeline. Primary sources come first, and archive links are kept where possible.

1 of these are overseas sites (Wikipedia, the Internet Archive, etc.) that may be unreachable from mainland China, so domestic sources (Baidu Baike, mainstream financial media, exchange filings) have been added wherever possible.

  1. [1]
    维基百科:GSK China scandal 其他 Overseas site
    Wikipedia Accessed 2026-10-04